shortagewatch

Home / Olmesartan Medoxomil / Italy

IT ATC C09CA08 · updated 2 Nov 2026

Olmesartan Medoxomil shortage in Italy

Is there an Olmesartan Medoxomil shortage in Italy?

Yes. As of 2 Nov 2026, 13 Olmesartan Medoxomil products are reported short in Italy, the first since 30 Jul 2022. The company estimate for the return is 30 Jun 2027. Main reason: manufacturing problem.

Also short in Canada, Spain, Belgium, Japan. All countries.

Affected products in Italy

CountryProductCompanySinceExpected backReason
ITOLMESARTAN MEDOXOMIL ZENTIVAZENTIVA ITALIA S.R.L.30 Jul 2022not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL ZENTIVAZENTIVA ITALIA S.R.L.30 Jul 2022not givenManufacturing problem
Problemi produttivi: forniture discontinue
ITOLMESARTAN MEDOXOMIL ACCORDACCORD HEALTHCARE, S.L.U.30 Oct 2025not givenIncreased demand
Elevata richiesta
ITOLMESARTAN MEDOXOMIL ACCORDACCORD HEALTHCARE, S.L.U.25 Dec 2025not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL ACCORDACCORD HEALTHCARE, S.L.U.24 Apr 2026not givenIncreased demand
Elevata richiesta
ITOLMESARTAN MEDOXOMIL MYLANMYLAN S.P.A.1 Jul 2026not givenManufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL SANDOZSANDOZ S.P.A.14 Sep 2026not givenIncreased demand
Elevata richiesta (carenza relativa solo al canale retail)
ITOLMESARTAN MEDOXOMIL PENSATOWA PHARMACEUTICAL S.P.A.1 Nov 202630 Jun 2027Manufacturing problem
Problemi produttivi
ITOLMESARTAN MEDOXOMIL ZENTIVA anticipatedZENTIVA ITALIA S.R.L.30 Nov 2026not givenIncreased demand
Elevata richiesta
ITOLMETEC anticipatedDAIICHI SANKYO ITALIA S.P.A.30 Nov 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITOLMETEC anticipatedDAIICHI SANKYO ITALIA S.P.A.30 Nov 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITOLMETEC anticipatedDAIICHI SANKYO ITALIA S.P.A.30 Nov 2026not givenManufacturing problem
Problemi produttivi: distribuzione contingentata
ITOLMESARTAN MEDOXOMIL AUROBINDO anticipatedAUROBINDO PHARMA (ITALIA) S.R.L.9 Dec 2026not givenIncreased demand
Elevata richiesta/problemi produttivi

Source

AIFA (Italian Medicines Agency), licensed CC-BY 4.0. Official list. All shortages reported by marketing-authorisation holders, including medicines being withdrawn.